The community acquired respiratory viruses (CRV) are well recognized as causes of fatal pneumonia after hematopoietic cell transplantation (HCT). Recent studies, however, suggest that the impact of CRV infection on overall survival after HCT may be far greater than commonly appreciated. Over 25% of long-term survivors of HCT are afflicted by significant decline in pulmonary airflow that is usually associated with the pathologic condition known as bronchiolitis obliterans; patients with such severe airflow obstruction (AFO) have mortality rates that are over twice as high as those without AFO. Though transplant-related AFO is currently believed to represent a pulmonary manifestation of chronic graft vs. host disease (GvHD), our preliminary data suggests that the CRVs are involved in the pathogenesis of this fatal transplant complication. We hypothesize that incident CRV infection after HCT is the trigger that leads to chronic pulmonary injury leading to AFO. We propose a large observational cohort study (N=500) with testing of weekly nasal wash specimens and clinically obtained BAL and lung biopsy specimens by quantitative RT-PCR testing for viral RNA of the major CRVs (RSV; influenza A, B; parainfluenza virus 1-4, RSV A, B; human metapneumovirus, rhinoviruses, coronaviruses, adenoviruses). These results will be correlated with the occurrence of AFO as determined by both scheduled standard pulmonary function tests and weekly measurements using portable electronic spirometers.
Specific Aim 1 will evaluate the association between incident infection with community-acquired respiratory viruses and the subsequent development of airflow obstruction after HCT. Specifically, we will determine the magnitude of the association, the differential risk of different viral species, and if the effect is site-specific (upper vs. lower respiratory tract).
Specific Aim 2 will further define viral factors that are associated with the development of respiratory virus-associated AFO, including whether viral species, viral load, or duration of viral shedding are involved in the pathogenesis of this fatal transplant-related complication; host-specific factors such as recipient age, conditioning regimen and immunosuppressive treatment for GvHD.
Specific Aim 3 will examine the role of leukotrienes in the pathogenesis of virus-induced AFO. These studies will improve our understanding of the interaction between respiratory viruses and late pulmonary complications after HCT, which will ultimately enable us to formulate more rational treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL081595-02
Application #
7124292
Study Section
Special Emphasis Panel (ZRG1-CRFS (01))
Program Officer
Peavy, Hannah H
Project Start
2005-09-19
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$608,596
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ogimi, Chikara; Englund, Janet A; Bradford, Miranda C et al. (2018) Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State. J Pediatric Infect Dis Soc :
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Ogimi, Chikara; Krantz, Elizabeth M; Golob, Jonathan L et al. (2018) Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2293-2301
Xue, Katherine S; Stevens-Ayers, Terry; Campbell, Angela P et al. (2017) Parallel evolution of influenza across multiple spatiotemporal scales. Elife 6:
Boeckh, Michael; Gilbert, Peter B (2016) Search continues for a CMV vaccine for transplant recipients. Lancet Haematol 3:e58-9
Cheng, Guang-Shing; Campbell, Angela P; Xie, Hu et al. (2016) Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 22:925-31
Campbell, Angela P; Guthrie, Katherine A; Englund, Janet A et al. (2015) Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis 61:192-202
Seo, Sachiko; Renaud, Christian; Kuypers, Jane M et al. (2015) Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. Blood 125:3789-97
Chu, Helen Y; Englund, Janet A; Podczervinski, Sara et al. (2014) Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center. Biol Blood Marrow Transplant 20:844-51
Seo, S; Xie, H; Karron, R A et al. (2014) Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes. Bone Marrow Transplant 49:1205-11

Showing the most recent 10 out of 34 publications